Management of complicated biliary disease in the pediatric population

Andrea Doud1, Logan Bond2, Cynthia Downard2

  • 1Department of Surgery, University of Kentucky College of Medicine, Lexington, KY.

Surgery
|November 30, 2021
PubMed

Insights

Pediatric cholecystectomies for cholesterol stones and biliary dyskinesia are increasing. Complicated biliary disease, including choledocholithiasis and gallstone pancreatitis, requires careful consideration of endoscopic retrograde cholangiopancreatography before or after cholecystectomy.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Biliary Tract Disease

Background:

  • Cholesterol stones and biliary dyskinesia are now the leading reasons for pediatric cholecystectomy, surpassing hemolytic disease.
  • This study focuses on pediatric patients with complicated biliary disease, specifically choledocholithiasis and/or gallstone pancreatitis.

Purpose of the Study:

  • To determine the incidence of complicated biliary disease in pediatric patients.
  • To evaluate the optimal treatment strategies for these conditions.

Main Methods:

  • A 15-year retrospective review of pediatric cholecystectomies at a single children's hospital.
  • Data collected included patient factors, indications for surgery, and treatment outcomes.
  • Complicated disease was defined by imaging-confirmed choledocholithiasis or gallstone pancreatitis.

Main Results:

  • Out of 695 cholecystectomies, 103 (14.8%) had complicated biliary disease.
  • High-risk patients (with choledocholithiasis or common bile duct enlargement) were more likely to require endoscopic retrograde cholangiopancreatography/sphincterotomy (59.6%) compared to low-risk patients (23.2%).
  • No bile leak complications occurred in patients undergoing endoscopic retrograde cholangiopancreatography after cholecystectomy for choledocholithiasis.

Conclusions:

  • The incidence of complicated pediatric biliary disease from cholesterol stones mirrors that in adults.
  • Endoscopic retrograde cholangiopancreatography should be strongly considered for pediatric patients with imaging evidence of choledocholithiasis or common bile duct enlargement, potentially before cholecystectomy.
  • Pediatric patients without radiographic evidence of common duct stones can undergo laparoscopic cholecystectomy, with postoperative endoscopic retrograde cholangiopancreatography reserved for cases where it is indicated.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
140
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
18
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
563
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
317